ENDONOVO THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Endonovo Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Endonovo Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was 17.3 %, a 0.35% decline year-over-year.
  • Endonovo Therapeutics, Inc. annual Return On Equity for 2022 was 83.1 %, a 348% increase from 2021.
  • Endonovo Therapeutics, Inc. annual Return On Equity for 2021 was 18.6 %, a 491% increase from 2020.
  • Endonovo Therapeutics, Inc. annual Return On Equity for 2020 was 3.14 %, a 97.1% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 83.1 +64.5 +348% Jan 1, 2022 Dec 31, 2022
2021 18.6 +15.4 +491% Jan 1, 2021 Dec 31, 2021
2020 3.14 -104 -97.1% Jan 1, 2020 Dec 31, 2020
2019 107 +47.1 +79% Jan 1, 2019 Dec 31, 2019
2018 59.6 -36.6 -38.1% Jan 1, 2018 Dec 31, 2018
2017 96.2 +32.4 +50.8% Jan 1, 2017 Dec 31, 2017
2016 63.8 -42.6 -40% Jan 1, 2016 Dec 31, 2016
2015 106 Jan 1, 2015 Dec 31, 2015
2013 89 -45.3 -33.7% Jan 1, 2013 Dec 31, 2013
2012 134 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.